4//SEC Filing
Hirsch Stanley 4
Accession 0001209191-20-023807
CIK 0001566044other
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 5:22 PM ET
Size
9.9 KB
Accession
0001209191-20-023807
Insider Transaction Report
Form 4
Hirsch Stanley
Director
Transactions
- Award
Common Stock
2020-04-03+63,844→ 130,107 total - Award
Common Stock
2020-04-03+71,303→ 201,410 total - Award
Common Stock
2020-04-03+220,496→ 328,609 total(indirect: See footnote)
Footnotes (4)
- [F1]As disclosed by the Issuer in its Current Report on Form 8-K filed with the Securities and Exchange Commission on April 6, 2020, following the receipt of certain clinical trial results, Menlo Therapeutics Inc. ("Menlo") issued additional shares of its common stock pursuant to certain contingent stock rights ("CSRs") issued in connection with the March 9, 2020 merger (the "Merger") of Menlo and Foamix Pharmaceuticals Ltd. ("Foamix"), including pursuant to CSRs held by the Reporting Person. The issuance of shares pursuant to the CSRs resulted in an adjustment to the effective exchange ratio applicable to the Merger, from 0.5924 to 1.8006 (the "Final Exchange Ratio"). Menlo derivative securities issued in exchange for Foamix derivative securities in connection with the Merger were also adjusted pursuant to their terms to give effect to the Final Exchange Ratio. The transactions reported in these line items reflect the additional shares and restricted stock unit (continued in footnote 2)
- [F2](continued from footnote 1) awards that were received by the reporting person as a result of the foregoing.
- [F3]Securities are held by ZEAS Technology and Science Management Ltd., a company beneficially owned by Stanley Hirsch.
- [F4]Represents restricted stock unit awards, each of which by its terms represents a contingent right to receive one share of common stock of Menlo.
Documents
Issuer
Menlo Therapeutics Inc.
CIK 0001566044
Entity typeother
Related Parties
1- filerCIK 0001727864
Filing Metadata
- Form type
- 4
- Filed
- Apr 6, 8:00 PM ET
- Accepted
- Apr 7, 5:22 PM ET
- Size
- 9.9 KB